RALEIGH, N.C.–(BUSINESS WIRE)–NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that it filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Court”).
In connection with its … Read More
RALEIGH, N.C.–(BUSINESS WIRE)–NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that its Board of Directors has made a determination to pause the clinical program of the Company’s product candidate oral Pyridorin® for the treatment of diabetic nephropathy, effect … Read More
Dr. Parikh conducts an active patient-oriented research program investigating the translational and epidemiological aspects of acute kidney injury (AKI) and other kidney-related disorders. He is the Founder and Principal Investigator of the NIH-sponsored Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) consortium, which has conducted three large studies for validating novel kidney injury … Read More
Dr. McCullough directs cardiovascular education and research for the Baylor Health Care System and functions as Vice Chief of Medicine at Baylor University Medical Center. He is a Principal Faculty in internal medicine for the Texas A&M University Health Sciences Center and is an expert on the role of chronic kidney disease as a cardiovascular … Read More
Dr. Lewis is a nephrology specialist and researcher, holding multiple roles on the executive committee of the Collaborative Study Group (CSG) for the past twenty years. She has served as head of several NIH and industry-sponsored oversight and advisory panels and has published research in over 200 peer-reviewed journals. She currently sits on the FDA … Read More
Dr. Kovesdy has published research in over 260 peer-reviewed articles, in addition to numerous abstracts and book chapters. His research interests in nephrology are centered on epidemiology and outcomes, cardiovascular risk factors, metabolic abnormalities, and race-ethnicity, in addition to bone and mineral disorders in pre-dialysis chronic kidney disease. He is currently the Principal Investigator on … Read More
Dr. Bakris has published over 700 peer-reviewed articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He currently serves as a special government expert to the Centers for Medicare & Medicaid Services (CMS) and the FDA Cardiovascular and Renal Drugs Advisory Committee. He chaired the first National Kidney … Read More